The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
Published version of a preprint
Abstract
Purpose: Myeloid-derived suppressor cells (MDSC) are considered an important T-cell immunosuppressive component in cancer-bearing hosts. The factors that attract these cells to the tumor microenvironment are poorly understood. IL8 (CXCL8) is a potent chemotactic factor for neutrophils and monocytes. Experimental Design: MDSC were characterized and sorted by multicolor flow cytometry on ficoll-gradient isolated blood leucokytes from healthy volunteers (n = 10) and advanced cancer patients (n = 28). In chemotaxis assays, sorted granulocytic and monocytic MDSC were tested in response to recombinant IL8, IL8 derived from cancer cell lines, and patient sera. Neutrophil extracellular traps (NETs) formation was assessed by confocal microscopy, fluorimetry, and time-lapse fluorescence confocal microscopy on short-term MDSC cultures. Results: IL8 chemoattracts both granulocytic (GrMDSC) and monocytic (MoMDSC) human MDSC. Monocytic but not granulocytic MDSC exerted a suppressor activity on the proliferation of autologous T cells isolated from the circulation of cancer patients. IL8 did not modify the T-cell suppressor activity of human MDSC. However, IL8 induced the formation of NETs in the GrMDSC subset. Conclusions: IL8 derived from tumors contributes to the chemotactic recruitment of MDSC and to their functional control. Clin Cancer Res; 22(15); 3924–36. ©2016 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These cytokines could enhance migration of macrophages and MDSCs to the liver [64, 65] (Fig. 2).”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [65]
Citations
Cites
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
The prognostic landscape of genes and infiltrating immune cells across human cancers
Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., Nair, V. S., Xu, Y., Khuong, A., Hoang, C. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3909 · Cited by 3,163
Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood
Clark, S. R., Ma, A. C., Tavener, S. A., McDonald, B., Goodarzi, Z., Kelly, M. M., Patel, K. D., Chakrabarti, S., McAvoy, E., Sinclair, G. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1565 · Cited by 2,309
The Interleukin-8 Pathway in Cancer
Waugh, D. J. J., & Wilson, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4843 · Cited by 2,103
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
Baggiolini, M., Walz, A., & Kunkel, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114265 · Cited by 1,975
Urban, C. F., Ermert, D., Schmid, M., Abed, U. A., Goosmann, C., Nacken, W. K. F., Brinkmann, V., Jungblut, P. R., & Zychlinsky, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000639 · Cited by 1,720
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., & Ferri, L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67484 · Cited by 1,395
Cited by
Sorted by citations
Items 401–417 of 417
Nebot-Bral, L. (2021) · theses.fr (ABES) · doi:10.70675/e1797b79z28d4z4e65zbd29zdc771b604d21
Wu, Y., Yaoqi, C., Mao, J., Li, K., He, Q., & Zhou, Z. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1694005
“Both IL-6 and IL-8 possess chemotactic activity, recruiting neutrophils and monocytes to in fl amed tissues (30, 31).”
Mardelle, U. (2024) · theses.fr (ABES) · doi:10.70675/1e786d9ez8d0ez41b3z8ac1z367faf59ae53
Mališ, V., Drakul, M., Rakočević, S., Kozić, L., Dubovina, A., Popović, D., Bokonjić, D., Mihajlović, D., & Čolić, M. J. (2026) · Molecules · doi:10.3390/molecules31081257
Suenaga, M., Mashima, T., Kawata, N., Dan, S., Seimiya, H., & Yamaguchi, K. (2026) · ESMO Gastrointestinal Oncology · doi:10.1016/j.esmogo.2026.100323
Why CAR T cell therapy fails in renal cell carcinoma
Hua-jun, Z., Han, L.-Z., Zhang, X., & Ge, Y.-L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1828738 · Cited by 1
Xue, N., Gong, H., Chen, W.-X., Zhao, X., Li, S., Ji, M., Lai, F.-F., Chen, X.-G., & Jin, J. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.06.032
Henderson, E. A., Łukomski, S., & Boone, B. A. (2026) · Technology in Cancer Research & Treatment · doi:10.1177/15330338261470694
“78 These studies discern an indirect role of NETs in immunosuppression through feedback loops with cancer cells.”
Chen, P., Lin, Y., Li, J., Gu, Y., & Zhang, X. (2026) · Genes · doi:10.3390/genes17080921
Mikeska, R. G., Feldman, L. E., Woodruff, E. R., Iwanaga, R., Linder, K., Yamamoto, T. M., Sompel, K. M., Jordan, K. R., Post, M. D., Zoller, M., et al. (2026) · Cancer Research Communications · doi:10.1158/2767-9764.crc-26-0408
“CXCR2i can decrease NET formation by neutrophils (14, 46), and NETs are associated with increased tumor growth and progression (46).”
Hadi, J. A., Nizami, Z. N., Noor, A. T., Osman, A. A., & Myers, J. N. (2026) · Cancers · doi:10.3390/cancers18172724
Pang, L., Liu, Y., Zhou, F., Guo, S., Khan, F., Ali, H. A., Shah, H., Huber, S., Kofler, B., Horbinski, C., et al. (2026) · Nature Cancer · doi:10.1038/s43018-026-01221-3
“…the accumulation of mMDSCs is driven by tumor-derived chemokines, such as CCL2 and macrophage migration inhibitory factor 43,44 , whereas the infiltration of gMDSCs is triggered by cancer cell-derived CXCL1/2 in mice and IL-8 in humans 45,46 , mediated through the chemokine receptor CXCR2 (ref.”
Armoring CAR-T Cells Against Exhaustion: Engineering Strategies for Glioblastoma
Anvarian, A., Nazari, F. S. M., & Karimi-Jashni, A. (2026) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000617
Zhang, X., Chao, J., 纪竹青, & Chen, K. (2026) · Journal of Chemotherapy · doi:10.1080/1120009x.2026.2722740
Souza, J. L., Almeida, V. H., Martins-Cardoso, K., Carneiro, L. D. T., de Azevedo, V. R., de Moraes, G. N., & Monteiro, R. Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1912140
Cancer metastasis: biological mechanisms, therapeutic bottlenecks, and emerging interventions
Ye, H., Wei, Y., He, X., & Wei, X. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01856-w
Tu, L., Yi, M., Feng, Z., Wang, Y., Ni, T., Zhou, L., Luo, B., Tang, Y., Ruan, S., Yan, W., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2026-016095
Metadata
- Authors
- Alfaro, C., Teijeira, A., Oñate, C., Pérez, G., Sanmamed, M. F., Andueza, M. P., Alignani, D., Labiano, S., Azpilikueta, A., Rodriguez-Paulete, A., Garasa, S., Fusco, J. P., Aznar, A., Inogés, S., De Pizzol, M., Allegretti, M., Medina-Echeverz, J., Berraondo, P., Perez-Gracia, J. L., & Melero, I.
- Affiliations
- Clinica Universidad de Navarra (ES)
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
- Centro de Investigación Médica Aplicada (ES)
- 5Dompé Farmaceutici SpA, L'Aquila, Italy.
- 2Department of Oncology, University Clinic of Navarra, Pamplona, Spain.
- ORCID
- Venue
- Clinical Cancer Research
- Published
- 2016-07-31
- Volume
- 22
- Issue
- 15
- Pages
- 3924-3936
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2298626553
- Cited by
- 417
- References
- 53
- Citations by year
- 2026: 35 · 2025: 33 · 2024: 44 · 2023: 54 · 2022: 54 · 2021: 59 · 2020: 46 · 2019: 35 · 2018: 22 · 2017: 21 · 2016: 13
- FWCI
- 18.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- interleukin-8, myeloid-derived suppressor cells, neutrophil extracellular traps, tumor microenvironment, chemotaxis, granulocytic MDSCs, monocytic MDSCs, T cell suppression, tumor immunosuppression, tumor-derived cytokines
- MeSH terms
- Myeloid-Derived Suppressor Cells, Animals, Chemotaxis, Leukocyte, Disease Models, Animal, Humans, Neoplasms, Neutrophils, Sulfonamides, Biomarkers, T-Lymphocyte Subsets, Interleukin-8, Mice, Knockout, Cell Line, Tumor, Mice, Extracellular Traps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review